Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Ionis scraps Alzheimer’s drug for people with Down syndrome

Summary by endpoints.news
Ionis Pharmaceuticals has ended the development of a potential medicine for people with Down syndrome who are at risk of Alzheimer’s disease, Endpoints News has learned. A spokesperson for the California biotech confirmed that the ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

endpoints.newsendpoints.news

Ionis scraps Alzheimer’s drug for people with Down syndrome

Ionis Pharmaceuticals has ended the development of a potential medicine for people with Down syndrome who are at risk of Alzheimer’s disease, Endpoints News has learned. A spokesperson for the California biotech confirmed that the ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Friday, February 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Alzheimer's Disease icon

Alzheimer's Disease

Alzheimer's Disease icon

Alzheimer's Disease

California, United States icon

California, United States

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal